Decera Clinical Education Infectious Disease Podcast

In this episode, Winnie Sseruma and Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, discuss some of the barriers to genuinely patient-centered HIV care in Africa and offer calls to action for healthcare professionals for responding to patient preferences. They discuss the efforts to improve patient-centered HIV care in the foundations and organizations for which they work. They also address is...

In this episode, Iskandar Azwa, MBChB, and patient advocate Andrew Tan Tze Tho discuss barriers to genuinely patient-centered HIV care in Malaysia and the surrounding region and offer calls to action for healthcare professionals for responding to patient preferences. They discuss health literacy programs and other forms of effective health communication, especially with respect to disparate commun...

In this episode, Jill Blumenthal, MD, MAS, and Jennifer Cocohoba, PharmD, share how they manage possible antiretroviral (ARV)-associated toxicities in transgender individuals, including: Strategies on how to approach different ARV-related toxicities Other factors to consider when assessing possible ARV-related toxicities (eg, weight gain, cardiovascular disease), such as gender-affirming care and...

In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from AASLD 2022, including: Hepatitis B Prevention of HBV vertical transmission when HBIg is unavailable Therapeutic vaccination for HBV cure Antiviral therapy to prevent HCC in patients with CHB in the indeterminate phase Hepatitis delta HDV prevalence in ethnically diverse, urban, safety-net populations Bulevirtide ± pegIFN-α...

In this episode, Marion Elligsen, BScPhm, MSc, RPh, ACPR; Keith S Kaye, MD, MPH; and Andrew Shorr, MD, MPH, MBA, discuss key considerations for selecting empiric antibiotic regimens in patients with HABP/VABP in the intensive care unit, including:  The role of novel β-lactam/β-lactamase inhibitor combinations Use of clinical predictions scores (eg, Drug Resistance in Pneumonia [DRIP] score) to pre...

In this episode, Nancy Reau, MD, shares her thoughts on the most practice-changing viral hepatitis data from AASLD 2022, including: Novel therapeutics for HBV HCV management strategies HDV screening and linkage to care Fatty liver disease in persons with viral hepatitis Use of statins to decrease morbidity and mortality in persons with liver disease Presenter: Nancy Reau, MD Professor of Medicine...

In this episode,  Chloe Orkin, MBChB, FRCP, MD, and Babafemi Taiwo, MBBS, discuss new HIV data presented at IDWeek and HIV Glasgow 2022, including Prevention strategies LA therapies Investigational agents Presenters: Chloe Orkin, MBChB, FRCP, MD Professor of HIV Queen Mary, University of London Consultant Physician Lead for HIV Research Barts Health NHS Trust The Royal London Hospital London, Unit...

In this episode, Jason Gallagher, PharmD, and Emily Heil, PharmD, MS, BCIDP discuss landmark clinical trials of COVID-19 antivirals for nonhospitalized patients and COVID-19 rebound phenomenon, including:   EPIC-HR study of nirmatrelvir plus ritonavir PINETREE study of remdesivir MOVe-OUT and Panoramic studies of molnupiravir COVID-19 rebound in treated and untreated patients Presenters: Jason Gal...

In this episode, Princy N. Kumar, MD, and Paul E. Sax, MD, discuss new COVID-19 data from IDWeek 2022, including: COVID-19 vaccines, including omicron BA.1 bivalent booster Risk factors for breakthrough COVID-19 infections COVID-19 diagnostics, including digital droplet PCR COVID-19 therapeutics, including: Nirmatrelvir plus ritonavir Tixagevimab plus cilgavimab Baricitinib Tocilizumab Inhaled int...

In this episode, Nneka Holder, MD, MPH, shares various strategies to improve meningococcal vaccine uptake in adolescent patients, including:  Use of school vaccine mandates beyond entry requirements Promote more frequent visits by incorporating immunization platforms and using text or email reminders to bring patients back to the office Schedule follow-up visits before patients leave the office to...

This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses solutions to expanding PrEP uptake. His discussion includes:  Potential healthcare professional barriers to prescribing PrEP Addressing t...

This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, focuses on transgender women. His discussion includes:  Barriers to PrEP uptake in transgender women High PrEP adherence among transgender women an...

This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses barriers to PrEP uptake for people who inject drugs. His discussion includes:  PrEP uptake and recommendations for people who inject drug...

This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses PrEP uptake for cisgender women. His discussion includes:  Prevalence of PrEP use in cisgender women in the United States Barriers to PrE...

This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses barriers to PrEP uptake in the context of racial inequities, specifically for Black and Latinx communities. His discussion includes:  Ine...

This episode is part of a larger discussion that comes from “Partnering With Patients: Overcoming Barriers to HBV Care in Asian Communities in the US .” Hear from Thuan Vu, MD, as he discusses linkage to care after HBV diagnosis in Asian communities from a provider’s perspective. And listen to discussions with Jennifer Wild, MSN, BSN, RN, OCN, and Melinda Tran as they consider his story from a pat...

In this episode, Paul E. Sax, MD, discusses long-acting (LA) injectables for HIV treatment, including:  Guidance on the use of LA cabotegravir (CAB) + rilpivirine (RPV) Risk factors for virologic failure of LA CAB + RPV The ATLAS-2M study Combined clinical trials of LA CAB + RPV Practical considerations for LA CAB + RPV Implementation of LA CAB + RPV  Switching to LA CAB + RPV without an oral lead...

In this episode, Paul E. Sax, MD, discusses the latest recommendations and options for HIV pre-exposure prophylaxis (PrEP), including: CDC PrEP guideline 2021 updates for oral PrEP The ANRS IPERGAY study: on-demand oral emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) PrEP in men who have sex with men who are at high risk for HIV infection A review of the HPTN 083 and 084 studies: efficacy...

In this episode, Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD​, discusses strategies for and importance of HIV care engagement and reengagement for those who have fallen out of care. Her overview includes: WHO Global Health Strategy on HIV Longitudinal HIV care trajectories Promotion of successful care and antiretroviral therapy (ART) adherence Differentiated service delivery Improving care...

This episode is part of a larger discussion that comes from “Partnering With Patients: Overcoming Barriers to HBV Care in Asian Communities in the US . ” First, Melinda Tran discusses treatment and retention of HBV care in Asian Communities in the US with Jennifer Wild, MS, BSN, RN, OCN, and Thuan Vu, MD. Their conversation offers an interesting mix of insights from the point of view of patient ad...

Patient advocate Bright Ansah shares some issues he encountered while seeking treatment after his diagnosis with HBV, including limited follow-up on lab results and a lack of compassion from his healthcare providers, and rushed health appointments. Bright’s story opens up a conversation about broader concerns about HBV treatment and retention in care with Janet Afoakwah and William Amiteye, fellow...

Listen as patient advocate William Amiteye uses his own experience as a Tanzanian immigrant to discuss important barriers to effective HBV screening and diagnosis, including limited knowledge about HBV from his healthcare providers, a lack of compassion toward his diagnosis from those same providers, and a limited awareness of HBV from patients in general. His story opens up an interesting and imp...

This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses barriers to PrEP uptake for adolescents. His discussion includes:  How PrEP is underused in adolescents and young adults Healthcare profe...

In this episode, Marc Thompson and Tristan J. Barber, MA, MD, FRCP, discuss some of the barriers to genuinely patient-centered HIV care in the United Kingdom and offer calls to action for healthcare professionals for responding to patient preferences. They discuss barriers to HIV testing and effectively communicating the benefits of testing to disparate communities. They also talk through the diff...

In this episode, hear Marta Boffito, MD, PhD, FRCP, and Julian Falutz, MD, FRCPC, discuss their approach to minimizing antiretroviral (ARV)-related intolerances in older patients with HIV, including: Consequences of polypharmacy Deprescribing ARV and non-ARV medications Complications associated with aging (eg, geriatric syndromes such as falls, frailty, multimorbidity) Mediations to avoid, such as...